- Institutional Review Board (IRB)
- Getting Started
- FAQ's and Tips
- For IRB Members
- For Research Participants
- Forms and Instructions
- General Guidelines
- Investigator Resources
- IRB Policies and FWA
- Meeting Dates and Deadlines
- Quality Assurance Review (QAR)
- Scientific Review
- Training and Education
- Use of Central/External IRBs
- NCI CIRB
- Quorum Review IRB
- Schulman Associates IRB (SAIRB)
- StrokeNet/External IRB
- WIRB/Copernicus Group
- IRB Suggestion Form
- Contact IRB
NCI CIRB (CIRB) is a central IRB that conducts IRB review of selected NCI-sponsored trials. It is open only to NCI-sponsored trials and SLU- and CIRB-approved Principal Investigators. If a PI has interest in becoming an authorized investigator, contact Melissa Fink, IRB Director, at email@example.com or 977-9814.
Can I use CIRB?
A clinical trial may be eligible for submission to CIRB if it meets all of the following criteria:
- Proposed research has active CIRB approval (https://ncicirb.org/)
- Proposed research will be conducted by a CIRB-approved PI
- Proposed research does not involve prisoners
What steps do I take to submit to CIRB?
Use the NCI CIRB Application to gain authorization from SLU to submit to CIRB. Note that CIRB-SLU Boilerplate language must be incorporated into the locally-developed consent/assent forms. The SLU site is also responsible for developing a HIPAA Authorization form for local use.
What do I need to do after approval?
CIRB and Saint Louis University each have responsibilities for overseeing this research, thus there are reporting requirements to both organizations. Refer to the Guidelines for using NCI CIRB for specific requirements.
Questions about the CIRB process and SLU requirements should go to Emily Harrison at firstname.lastname@example.org or 314-977-7741.
Questions regarding CIRB submission and reporting requirements are best handled by contacting CIRB directly or by visiting https://www.ncicirb.org/.